ConductScience.org, home

Paper26323609

PD-L1 expression and prognostic impact in glioblastoma.

Nduom EK and 17 others. Neuro Oncol, 2016. Cited by 500 papers, by iCite.

Cite this record

ConductScience Library. PD-L1 expression and prognostic impact in glioblastoma. Papers, record 26323609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26323609

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PD-L1 expression and prognostic impact in glioblastoma.
PubMed
Journal
Neuro Oncol
PubMed
Year
2016
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
500
iCite
Relative citation ratio, by iCite
16
iCite
Revised in PubMed
2023-04-13
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nduom EKEdjah K
2Wei JJun
3Yaghi NKNasser K
4Huang NNeal
5Kong LYLing-Yuan
6Gabrusiewicz KKonrad
7Ling XXiaoyang
8Zhou SShouhao
9Ivan CCristina
10Chen JQJie Qing
11Burks JKJared K
12Fuller GNGreg N
13Calin GAGeorge A
14Conrad CACharles A
15Creasy CCaitlin
16Ritthipichai KKrit
17Radvanyi LLaszlo
18Heimberger ABAmy B

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
B7-H1 AntigenMajor topic
Biomarkers, TumorMajor topic
Brain NeoplasmsMajor topic
GlioblastomaMajor topic
T-LymphocytesMajor topic
Adult
Aged
Animals
Cell Line, Tumor
Cell Proliferation
Female
Flow Cytometry
Follow-Up Studies
Gene Expression Regulation, Neoplastic
Humans
Immunoenzyme Techniques
Male
Mice
Middle Aged
Neoplasm Staging
Prognosis
RNA, Messenger
Survival Rate

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA120813NCI NIH HHSUnited StatesR01CA120813PubMed and NIHNIH RePORTER
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMed and NIHNIH RePORTER
P50 CA093459NCI NIH HHSUnited StatesP50CA093459PubMed and NIHNIH RePORTER
CA1208113NCI NIH HHSUnited StatesPubMedPubMed
P50 CA127001NCI NIH HHSUnited StatesP50CA127001PubMed and NIHNIH RePORTER

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125355681Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.Neuro Oncol2015https://conductscience.org/library/papers/25355681PubMed
225193987PD-L1 expression in nonclear-cell renal cell carcinoma.Ann Oncol2014https://conductscience.org/library/papers/25193987PubMed
322290259Immunotherapy for the treatment of glioblastoma.Cancer J2012https://conductscience.org/library/papers/22290259PubMed
419202065B7-H1 (PD-L1) on T cells is required for T-cell-mediated conditioning of dendritic cell maturation.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19202065PubMed
525034862Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.Lancet2014https://conductscience.org/library/papers/25034862PubMed
617629517Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.Immunity2007https://conductscience.org/library/papers/17629517PubMed
723986257PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients.J Neurosci2013https://conductscience.org/library/papers/23986257PubMed
820667896Glioma cancer stem cells induce immunosuppressive macrophages/microglia.Neuro Oncol2010https://conductscience.org/library/papers/20667896PubMed
916723631An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.Neuro Oncol2006https://conductscience.org/library/papers/16723631PubMed
1024409449Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.Cancer Immunol Res2013https://conductscience.org/library/papers/24409449PubMed
1123833564Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma.Cancer Immun2013https://conductscience.org/library/papers/23833564PubMed
1223977046Large scale comparison of gene expression levels by microarrays and RNAseq using TCGA data.PLoS One2013https://conductscience.org/library/papers/23977046PubMed
1325635347A new initiative on precision medicine.N Engl J Med2015https://conductscience.org/library/papers/25635347PubMed
1422441249PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia.AIDS2012https://conductscience.org/library/papers/22441249PubMed
1524691018Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.Clin Cancer Res2014https://conductscience.org/library/papers/24691018PubMed
1617159987Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma.Nat Med2007https://conductscience.org/library/papers/17159987PubMed
1725586468A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.Neuro Oncol2015https://conductscience.org/library/papers/25586468PubMed
1825594174Molecular and genetic properties of tumors associated with local immune cytolytic activity.Cell2015https://conductscience.org/library/papers/25594174PubMed
1918585785Interaction of human PD-L1 and B7-1.Mol Immunol2008https://conductscience.org/library/papers/18585785PubMed
2023724846Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.N Engl J Med2013https://conductscience.org/library/papers/23724846PubMed

See all 41 referencesDownload CSV of references

Cited by398

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 500 citations.

PMIDTitleJournalYearIn PapersSource
42965172Corticosteroid treatment modulates immune cell populations in the glioblastoma microenvironment.Neurooncol Adv2026https://conductscience.org/library/papers/42965172PubMed
42958266MRgFUS-enabled nanogel platform for synergstic chemo-immunotherapy in glioblastoma.J Nanobiotechnology2026https://conductscience.org/library/papers/42958266PubMed
42699700Newcastle Disease Virus - Induced Interferons Regulate PD-L1 and MICA Expression in Human Tumor and Normal Cells.Immunotargets Ther2026https://conductscience.org/library/papers/42699700PubMed
42652167EFEMP2 Is Associated with Shelterin-Related DNA Damage Repair, Immune Microenvironment Features, and Prognosis in Glioblastoma.Biomedicines2026https://conductscience.org/library/papers/42652167PubMed
42649887Fatty Acid Metabolism Rewires Glioblastoma Progression and Treg-Mediated Immune Resistance.Cancers (Basel)2026https://conductscience.org/library/papers/42649887PubMed
42549384Glioblastoma beyond the Brain: A Case Series Demonstrating Systemic Metastatic Potential.Case Rep Oncol2026https://conductscience.org/library/papers/42549384PubMed
42396877Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment.Immunol Cell Biol2026https://conductscience.org/library/papers/42396877PubMed
42101535Glioblastoma: epidemiology, molecular pathogenesis, diagnosis, management, and therapeutic resistance.Mol Biomed2026https://conductscience.org/library/papers/42101535PubMed
41995753Extracellular vesicles mediate intercellular transfer of PD-L1 and bystander T-cell suppression.Cell Mol Life Sci2026https://conductscience.org/library/papers/41995753PubMed
41909736Targeting immunosuppressive network in glioblastoma: Emerging strategies to overcome immunodeficiency and enhance therapeutic efficacy.Acta Pharm Sin B2026https://conductscience.org/library/papers/41909736PubMed
41851421Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme.Commun Med (Lond)2026https://conductscience.org/library/papers/41851421PubMed
41689429The Application of PD-1 Inhibitors in Immunotherapy for Glioblastoma.FASEB J2026https://conductscience.org/library/papers/41689429PubMed
41617829Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas.Sci Rep2026https://conductscience.org/library/papers/41617829PubMed
41583467Recent advances in immunotherapy for gliomas: overcoming barriers and advancing precision strategies.Front Immunol2025https://conductscience.org/library/papers/41583467PubMed
41579222From Classical to Emerging Biomarkers of Brain and Central Nervous System Tumors. An Evidence-Based Review with a Focus on Gliomas.Cell Mol Neurobiol2026https://conductscience.org/library/papers/41579222PubMed
41578162MRPS16 Regulates NFATC2 Through the Wnt/β-Catenin Pathway to Promote Glioma Proliferation.J Cell Mol Med2026https://conductscience.org/library/papers/41578162PubMed
41577996Dual biomarker role of PD-L1 and LC3B in glioblastoma: prognostic and therapeutic potential.Neurosurg Rev2026https://conductscience.org/library/papers/41577996PubMed
41438616A Cuproptosis-Related lncRNA Signature Predicts Prognosis and Shapes the Immune Landscape in Primary Lower-Grade Glioma.Genet Res (Camb)2025https://conductscience.org/library/papers/41438616PubMed
41433099Mismatch repair deficiency drives malignant progression and alters the tumor immune microenvironment in glioblastoma models.J Clin Invest2026https://conductscience.org/library/papers/41433099PubMed
41395274Study on the anti-tumor effect of PDL1-CAR-γδT cells constructed with nanobody sequences on glioblastoma.Am J Cancer Res2025https://conductscience.org/library/papers/41395274PubMed

See all 398 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
SPATA29825PubTator's text mininghttps://conductscience.org/library/genes/9825NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26323609

GET https://conductscience.org/api/papers/v1/26323609/references?page=2